{
    "symbol": "AXNX",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-01 22:59:08",
    "content": " Your line is now open. Your line is now open. Your line is now open. Your line is now open. Your line is now open. Your line is now open. It's not to say that we won't add additional, let's say, things that could make things easier in the future, et cetera, et cetera, but we're going to kind of focus in this area of incontinence and for the foreseeable future and then we'll reevaluate, but our goal is as we've stated, number one, market leadership in sacral neuromodulation and we are more than three-quarters of the way to that goal right now, so we're going to continue to press that hard and we'd like to be a $0.5 billion company, and we think that's within our grasp and then maybe things change for us, and we have more levers to push at that point, but you're not going to be surprised by some announcement that all of a sudden, we decided to get into BPH or something like that, that's not the direction that we're thinking about, so I appreciate the question. Your line is now open. Your line is now open. Your line is now open."
}